BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2014
View Archived Issues
Novel S1P1 receptor ligands designed by Allergan
Read More
Scientists at Purdue Pharma divulge new opioid receptors ligands
Read More
Chinese companies disclose new PI3Kalpha inhibitors
Read More
Domainex reports promising preclinical data for lead compound in model of COPD
Read More
NIH funds phase II trial of NeuroSigma's eTNS System
Read More
Biosceptre raises funds for development of BIL-221-s
Read More
Insys Therapeutics completes human abuse study for dronabinol
Read More
CNX-013-B2, a pan-PPAR activator for diabetes and obesity
Read More
Biological characterization of a first-in-class, small-molecule, anticancer kinetochore inhibitor
Read More
Kyoto Pharmaceutical's PTP-1B inhibitor, a promising candidate for diabetes and obesity
Read More
Clinical results reported for TTP-399, a liver-selective GKA for type 2 diabetes
Read More
Beloranib granted orphan drug status in the E.U. for Prader-Willi syndrome
Read More
Evzio auto-injector available in the U.S. for emergency treatment of opioid overdose
Read More
Merck & Co. discloses new Mdm2 inhibitors
Read More
Sarepta Therapeutics reports long-term data from phase IIb study of eteplirsen
Read More
Quanticel prepares novel histone demethylase inhibitors
Read More
TransTech Pharma agrees with FDA on special protocol assessment for TTP-488
Read More
Givinostat shows activity in models of glioblastoma
Read More
MabVax Therapeutics and Telik finalize merger
Read More
Baxter acquires AesRx
Read More
NDA for Kythera Biopharmaceuticals' ATX-101 accepted
Read More
Glenmark initiates first-in-human trial of MPGES-1 inhibitor
Read More
Viamet reports new phase IIa data on VT-1161 in tinea pedis and acute vulvovaginal candidiasis
Read More
Bristol-Myers Squibb plans Q3 BLA for Opdivo in advanced melanoma
Read More
Takeda plans phase I study of ixazomib citrate in lupus nephritis
Read More